semaglutide for eating disorder GLP-1 and Disorders: Risks & Recovery Info Still hungry on semaglutide? 9

Ten-year changes in plasma L-carnitine levels and risk of coronary heart disease

Lancet Diab Endocrinol 2:885893 Nauck MA (2011) Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications

Comparative analysis of skin characteristics evaluation by a dermatologist and the Janus-III measurement system

If this is the case, youve likely stumbled upon keto and Ozempic

Trial Results vs Real-World Expectations Factors That Affect Individual Results Maximum tolerated dose: Not everyone can reach 12mg due to side effects Adherence: Missing doses or inconsistent timing reduces efficacy Baseline metabolic health: Insulin resistance, PCOS, thyroid issues affect response Age: Metabolic rate naturally declines with age, affecting weight loss velocity Genetics: Some people are better responders to GLP-1 medications than others Concurrent medications: Certain drugs (antipsychotics, corticosteroids) can blunt weight loss Sleep and stress: Poor sleep and high cortisol impair weight loss Protein intake: Inadequate protein accelerates muscle loss Realistic goal setting: If you're starting at 240 lbs, aim for 30-45 lbs lost in the first year on a 8-12mg protocol with lifestyle changes

A 2026 systematic review in the European Journal of Endocrinology found GLP-1 receptor agonists were associated with modest short-term weight loss in women with PCOS and overweight or obesity